126 related articles for article (PubMed ID: 23312611)
1. Effective inhibition of acid and neutral ceramidases by novel B-13 and LCL-464 analogues.
Bhabak KP; Kleuser B; Huwiler A; Arenz C
Bioorg Med Chem; 2013 Feb; 21(4):874-82. PubMed ID: 23312611
[TBL] [Abstract][Full Text] [Related]
2. Novel amide- and sulfonamide-based aromatic ethanolamines: effects of various substituents on the inhibition of acid and neutral ceramidases.
Bhabak KP; Arenz C
Bioorg Med Chem; 2012 Oct; 20(20):6162-70. PubMed ID: 22989912
[TBL] [Abstract][Full Text] [Related]
3. C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth.
Flowers M; Fabriás G; Delgado A; Casas J; Abad JL; Cabot MC
Breast Cancer Res Treat; 2012 Jun; 133(2):447-58. PubMed ID: 21935601
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer.
Selzner M; Bielawska A; Morse MA; Rüdiger HA; Sindram D; Hannun YA; Clavien PA
Cancer Res; 2001 Feb; 61(3):1233-40. PubMed ID: 11221856
[TBL] [Abstract][Full Text] [Related]
5. Targeting (cellular) lysosomal acid ceramidase by B13: design, synthesis and evaluation of novel DMG-B13 ester prodrugs.
Bai A; Szulc ZM; Bielawski J; Pierce JS; Rembiesa B; Terzieva S; Mao C; Xu R; Wu B; Clarke CJ; Newcomb B; Liu X; Norris J; Hannun YA; Bielawska A
Bioorg Med Chem; 2014 Dec; 22(24):6933-44. PubMed ID: 25456083
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity and acid ceramidase inhibitory activity of 2-substituted aminoethanol amides.
Bedia C; Canals D; Matabosch X; Harrak Y; Casas J; Llebaria A; Delgado A; Fabriás G
Chem Phys Lipids; 2008 Nov; 156(1-2):33-40. PubMed ID: 18760267
[TBL] [Abstract][Full Text] [Related]
7. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts.
Samsel L; Zaidel G; Drumgoole HM; Jelovac D; Drachenberg C; Rhee JG; Brodie AM; Bielawska A; Smyth MJ
Prostate; 2004 Mar; 58(4):382-93. PubMed ID: 14968439
[TBL] [Abstract][Full Text] [Related]
8. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells.
Morad SA; Levin JC; Tan SF; Fox TE; Feith DJ; Cabot MC
Biochim Biophys Acta; 2013 Dec; 1831(12):1657-64. PubMed ID: 23939396
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and bioevaluation of omega-N-amino analogs of B13.
Bai A; Szulc ZM; Bielawski J; Mayroo N; Liu X; Norris J; Hannun YA; Bielawska A
Bioorg Med Chem; 2009 Mar; 17(5):1840-8. PubMed ID: 19217788
[TBL] [Abstract][Full Text] [Related]
10. Ceramidases, roles in sphingolipid metabolism and in health and disease.
Coant N; Sakamoto W; Mao C; Hannun YA
Adv Biol Regul; 2017 Jan; 63():122-131. PubMed ID: 27771292
[TBL] [Abstract][Full Text] [Related]
11. Neutral ceramidase activity inhibition is involved in palmitate-induced apoptosis in INS-1 cells.
Luo F; Feng Y; Ma H; Liu C; Chen G; Wei X; Mao X; Li X; Xu Y; Tang S; Wen H; Jin J; Zhu Q
Endocr J; 2017 Aug; 64(8):767-776. PubMed ID: 28674283
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of a novel ceramide analogue and its use in a high-throughput fluorogenic assay for ceramidases.
Bedia C; Casas J; Garcia V; Levade T; Fabriàs G
Chembiochem; 2007 Apr; 8(6):642-8. PubMed ID: 17361980
[TBL] [Abstract][Full Text] [Related]
13. Neutral ceramidase-active site inhibitor chemotypes and binding modes.
Coant N; Bickel JD; Rahaim R; Otsuka Y; Choi YM; Xu R; Simoes M; Cariello C; Mao C; Saied EM; Arenz C; Spicer TP; Bannister TD; Tonge PJ; Airola MV; Scampavia L; Hannun YA; Rizzo RC; Haley JD
Bioorg Chem; 2023 Oct; 139():106747. PubMed ID: 37531819
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of Ceramidases.
Saied EM; Arenz C
Chem Phys Lipids; 2016 May; 197():60-8. PubMed ID: 26220616
[TBL] [Abstract][Full Text] [Related]
15. Measurement of neutral ceramidase activity in vitro and in vivo.
Simoes M; Saleh A; Choi YM; Airola MV; Haley JD; Coant N
Anal Biochem; 2022 Apr; 643():114577. PubMed ID: 35134389
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibition of Acid ceramidase by novel B-13 analogues.
Proksch D; Klein JJ; Arenz C
J Lipids; 2011; 2011():971618. PubMed ID: 21490813
[TBL] [Abstract][Full Text] [Related]
17. Neutral ceramidase gene: role in regulating ceramide-induced apoptosis.
Choi MS; Anderson MA; Zhang Z; Zimonjic DB; Popescu N; Mukherjee AB
Gene; 2003 Oct; 315():113-22. PubMed ID: 14557071
[TBL] [Abstract][Full Text] [Related]
18. Atom based 3D-QSAR studies on 2,4-dioxopyrimidine-1-carboxamide analogs: Validation of experimental inhibitory potencies towards acid ceramidase.
Bhattacherjee D; Bhabak KP
Eur J Pharm Sci; 2016 Feb; 83():8-18. PubMed ID: 26658266
[TBL] [Abstract][Full Text] [Related]
19. Benzoxazolone Carboxamides as Potent Acid Ceramidase Inhibitors: Synthesis and Structure-Activity Relationship (SAR) Studies.
Bach A; Pizzirani D; Realini N; Vozella V; Russo D; Penna I; Melzig L; Scarpelli R; Piomelli D
J Med Chem; 2015 Dec; 58(23):9258-72. PubMed ID: 26560855
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a new class of highly potent inhibitors of acid ceramidase: synthesis and structure-activity relationship (SAR).
Pizzirani D; Pagliuca C; Realini N; Branduardi D; Bottegoni G; Mor M; Bertozzi F; Scarpelli R; Piomelli D; Bandiera T
J Med Chem; 2013 May; 56(9):3518-30. PubMed ID: 23614460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
